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Introduction: Low back pain (LBP) is a significant cause of disability in many coun-
tries, affecting more than half a billion people worldwide. In the past, progenitor cells
have been found within the nucleus pulposus (NP) of the human intervertebral disc
(IVD). However, in the context of cell therapy, little is known about the effect of
cryopreservation and expansion on here called “heterogenic” human NP cells
(hNPCs), and whether commercially available cryopreservation media are more effi-
cient than “commonly used” media in terms of cell viability.
Materials: In this study, hNPCs from four trauma patients (age 40.5 ± 14.3 years) and two
patients with degenerated IVDs (age 24 and 46 years), undergoing spinal surgery, were col-
lected. To isolate hNPCs, the tissue was digested with a mild two-step protocol. After sub-
sequent expansion, hNPCs at passages 2-5 were separated and either cryo-preserved for
1 week at −150C or differentiated into osteogenic, adipogenic, or chondrogenic lineages
for 21 days. Cryopreservation was performed with five different media to compare their
effect on the cell's viability and differentiation potential. Cell viability was determined with
flow cytometry using propidium iodide and the trilineage differentiation potential was
assessed by quantitative polymerase chain reaction and histological analysis.
Results: After 1 week of cryopreservation, the hNPC's cell viability was comparable
for all conditions, that is, independent of the cryopreservation medium used (82.3
± 0.8% of cell viability). Furthermore, hNPCs from trauma patients showed some evi-
dence for adipogenic and chondrogenic differentiation and at lower levels, this and
evidence of osteogenic differentiation could be confirmed with hNPCs from
degenerated discs. Moreover, cryopreservation did not affect the cell's differentiation
potential in the majority of the cases tested.
Conclusion: “Commonly used” cryopreservation media seem to perform just as well
as commercially available media in terms of cell viability and the overall maintenance
of the hNPCs trilineage differentiation potential.
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1 | INTRODUCTION
1.1 | Intervertebral disc degeneration and low
back pain
A healthy intervertebral disc (IVD) mainly consists of a centrally
located, collagen type II rich and highly hydrated nucleus pulposus tis-
sue (NP). The NP is surrounded by the annulus fibrosus (AF), which is
composed of 15 to 25 concentric lamellae consisting of collagen type
I and II fibers with elastin fibers lying in between. Finally, the IVD is
enclosed by two hyaline cartilaginous endplates (CEP) above and
below them.1-3
The causes of IVD degeneration (IDD) are manifold. However, in
many cases, IDD is initiated by a decrease of the amount of NP cells
accompanied by a change of the extracellular matrix (ECM) composi-
tion, for example, by loss of the proteoglycan content.4 Degraded pro-
teoglycans tend to escape from the NP and osmotic imbalance results
as a consequence.5 This reduction of the osmotic pressure in the NP
will then lead to its dehydration and destruction, resulting in loss of
disc height.6 Other causes of IDD are changes in collagen repartitions
in the ECM. Especially type II collagen can become more and more
denatured over time and therefore contribute to IDD.7,8
While IDD per se may remain clinically silent, some conditions
associated with IDD cause symptoms ranging from mild, occasional
discomfort to severe, immobilizing back pain and disability.9 Conser-
vative management, including physical therapy, lifestyle modification,
pain- and anti-inflammatory medication is the first-line treatment of
back pain related to IDD. Failure of conservative measures may direct
towards surgical treatment.10,11 The spectrum of surgical procedures
is broad and relies on distinct pathologies. One of the most frequently
performed surgical intervention is spinal fusion with the purpose to
induce osseous fusion between at least two vertebrae and thereby
eliminating motion and relieving pain.12 However, the clinical success
rate of spinal fusion lies only between 50% and 70%, and more than
25% of the patients require reoperation, which still does not guaran-
tee successful fusion.13-15 Another primary concern of spinal fusion is
that these interventions do not have the intention to restore the IVD,
but instead leave the patient with a stiff and immobile spine, increas-
ing the risk for adjacent segment disease. Therefore, there is a high
demand for new efficient treatment techniques regarding LBP.
1.2 | Cell-based therapy for IDD
A promising approach to regenerate the IVD is cell-based therapy. Even
if it is still in its infancy, cell-based therapy has received more and more
attention over the last two decades.2 Especially targeting the NP is
believed to have considerable potential in this field.2 A previous study
showed the existence of NP derived mesenchymal stromal cells (MSCs)
that can differentiate into an osteogenic and chondrogenic lineage.
However, they were not able to differentiate into adipocytes.16 Addi-
tionally, over the last decade, progenitor cells positive for Tie2 (aka
angiopoietin-1 receptor / TEK receptor tyrosine kinase) and
disialoganglioside 2 (GD2+) have been found in the NP of humans and
other vertebrates.17,18 It has been shown that these rare cells can form
spheroid colonies in methylcellulose-based medium, and they are also
able to undergo trilineage differentiation.17 However, with increasing
age and continuous IDD, the amount of Tie2 positive cells in the IVD
rapidly decreases. In humans, the frequency of these cells already starts
to drop before the age of 20, with more than half of the NP cells usu-
ally being positive for Tie2.17 By the age of 50, the amount of Tie2 pos-
itive cells nearly completely vanishes.17,19
To conclude, the differentiation potential of MSCs and Tie2
positive cells from the NP has been demonstrated in recent years.
However, little is known about the effect of expansion and cryopreser-
vation on here called “heterogenic” human NP cell populations (hNPCs)
and their stemness in the context of cell therapy for regeneration of
the IVD.19 Thus, we hypothesized that “heterogenic” hNPCs could
undergo trilineage differentiation. Therefore, freshly isolated hNPCs
and previously frozen hNPCs (from the same donors) were cultured
either in osteogenic inductive medium, adipogenic inductive medium,
chondrogenic inductive medium, or control medium. After 21 days of
culture, multi-lineage differentiation properties were compared using
histology, absorbance measurements, and quantitative polymerase
chain reaction (qPCR).
1.3 | Cryopreservation
Cryopreservation has become an indispensable technology for bio-
medical research but also clinical medicine and it is even seen as the
gold standard for bio-preservation.20,21 However, freezing cells at
very low temperatures (−150C) for preservation faces many chal-
lenges in terms of cell viability. For example, the freezing rate plays a
critical role in successful cryopreservation as it underlies a delicate
balance between too fast and too slow cooling.20 If the cooling pro-
cess happens too fast, liquid water in the cell's body will undergo a
phase change and form ice crystals which potentially damage the
cells.22 In contrast, a too slow cooling rate will first cause extracellular
ice formation and as a consequence create an osmotic imbalance
between the intracellular and extracellular space. As more and more
extracellular ice forms, the concentration of particles in the residual
water will further increase causing greater osmotic imbalance and an
additional depression of the freezing point.23,24 As a result, intracellu-
lar water will efflux across the cell's membrane leading to dehydration
and in the worst case cause cell death.25
To avoid this ice crystal formation and to preserve osmotic bal-
ance, a cryoprotectant is added to the Mammalian cells and then
everything is usually cooled at a rate of −1C per minute.26 By defini-
tion, a cryoprotectant is a solute added to the medium that enables
higher cell recovery after thawing compared to its absence.27 Many
different cryoprotectants exist, one of which being dimethyl sulfoxide
(DMSO), which is most commonly used for mammalian cells.28,29
DMSO can cross the cell membrane and act as a solvent for salts. As a
consequence, the osmotic pressure diminishes, the freezing point
decreases, and intracellular ice crystal formation is depressed.24,26
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In the past, studies have shown that cryopreservation of human
adipose-derived mesenchymal stromal cells (ASCs) and bone marrow-
derived mesenchymal stromal cells (BMSCs) does not affect their via-
bility nor their trilineage differentiation potential.30,31 However, an
optimal way to cryo-preserve hNPCs is yet to be found for IVD cells
in general and only very little is known about the influence of cryo-
preservation on the cell viability and stemness of hNPCs.
Thus, we hypothesized that hNPCs can be cryo-preserved just as
well with “commonly used” cryopreservation media, made by simply
adding 10% dimethyl sulfoxide (DMSO), as with more complex com-
mercially available media without any significant differences con-
cerning cell viability. Additionally, we wondered if hNPCs can undergo
trilineage differentiation and if cryopreservation would affect this abil-
ity. Therefore, primary hNPCs were isolated from either trauma
patients or patients suffering from degenerated IVDs undergoing spi-
nal surgery. We cryopreserved the isolated hNPCs for 2 days at
−80C followed by 1 week's storage at −150C with five different
cryopreservation media. After testing the cell viability using flow cyto-
metry, the hNPCs' trilineage differentiation potential was assessed.
2 | MATERIALS AND METHODS
2.1 | Cell isolation
NP cells were isolated from human IVDs, which were obtained from
donors undergoing spinal surgery because of IDD (N = 2) or after
trauma, whereby IVDs should not be degenerated or at most only
mildly (N = 4) (Table 1). All patients provided written informed con-
sent after the project was approved by the local IRB (ethics committee
of the Canton of Bern, Ref. 2019-00097). The IVD tissue was then
dissected into nucleus pulposus (NP) tissue, annulus fibrosus
(AF) tissue, and cartilaginous endplate (CEP) tissue. In the next step,
the prepared pieces of each IVD tissue type were washed with
phosphate-buffered salt solution (PBS) and centrifuged for 5 minutes
at 500g. Afterwards, all three tissue types were first digested with
0.2% pronase (#10165921001; Roche Diagnostics, Mannheim, Ger-
many) for 1 hour and subsequently digested with collagenase type II
(255 U/mg; #LS004176; Worthington Biochemical Corporation, Lake-
wood, New Jersey) overnight. After overnight digestion, the cells
were washed with PBS, transferred into T150 flasks (#90151; TPP,
Trasadingen, Switzerland) and expanded in LG-DMEM “complete
medium” (low glucose Dulbecco's Modified Eagle Medium (1 g/L;
LG-DMEM; #31600-083; Thermo Fisher Scientific, Waltham,
Massachusetts) enriched with 0.22% sodium hydrogen carbonate
(#31437-500G-R; Sigma-Aldrich), 10% FBS (#F7524; Sigma-Aldrich),
1 mM sodium pyruvate (#11360-039; Thermo Fisher Scientific), penicil-
lin/streptomycin/glutamine (#10378-016; P/S/G, 100 units/mL,
100 μg/mL and 292 μg/mL, respectively; Thermo Fisher Scientific) and
10 mM HEPES buffer solution (#15630-056; Thermo Fisher Scientific).
Cells from the AF the CEP were frozen and the “heterogenous” hNPC
population was expanded until a sufficient number of cells were accom-
plished for future experiments. During cell expansion, the medium was
changed twice a week. Cells were cultured at 37C with normoxic con-
ditions (20% O2) and 5% CO2.
2.2 | Cell freezing
To find the most suitable cryopreservation medium for hNPCs, two
“commonly used” and three commercially available cryopreservation
media were tested. For the “commonly used” media we used either a
commonly applied cryo-medium for progenitor cells (CMPC) that con-
sisted of 90% FBS and 10% DMSO or a commonly applied cryo-medium
for differentiated cells (CMDC) that consisted of 90% LG-DMEM “com-
plete medium” and 10% DMSO. In addition, three commercially available
cryopreservation media were tested. One of them was the CellnTec
Cryo-Defined Freezing Medium (CnT) (#CnT-CRYO-50; CELLnTEC
Advanced Cell Systems Inc.; Bern, Switzerland), which was mixed with
50% LG-DMEM “complete medium” according to the product usage
requirements. The second commercially available cryopreservation
medium we tested was the cGMP-manufactured CryoStor CS10 (CS10)
(#07930; Biolife Solutions; Bothell, Washington) and as a last tested
medium, we took the MesenCult-ACF Freezing Medium (MesenCult)
(#05490; Stemcell Technologies; Vancouver, British Columbia, Canada).
The hNPCs were frozen at a density of 500 000 cells/mL of the
respective cryopreservation medium. In brief, the cell suspensions
were first stored in a pre-cooled Nalgene Cryo 1C freezing container
(#5100-0001; Thermo Fisher Scientific) filled with 2-propanol for
2 days at −80C to reduce ice crystal formation. Then, the cells
were removed from the freezing container and stored for 7 days
at −150C.
TABLE 1 Overview of the sex, age,
disc location, status of the received IVD
and Pfirrmann grade (if degenerated)
from all patients in this study
Donors of the study
Donor number Sex Age [years] Disc location IVD status (Pfirrmann)
#1 Male 50 Th11/Th12 & L1/L2 Trauma
#2 Male 55 Th11/Th12 & L1/L2 Trauma
#3 Male 32 L1/L2 Trauma
#4 Female 24 L5/S1 Degenerated (Grade 4)
#5 Female 46 L5/S1 Degenerated (Grade 4)
#6 Female 25 Th12/L1 & L1/L2 Trauma
Abbreviations: IVD, intervertebral disc; L, lumbar; S, sacral; Th, thoracic.
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2.3 | Cell thawing
To maximize hNPCs' viability, subsequent procedures were followed:
First, LG-DMEM “complete medium” was put into a prewarmed water
bath (37C). As soon as the medium reached the same temperature as
the water bath, the samples were removed from the −150C freezer.
Under sterile conditions, the cryovial's caps were twisted a quarter-
turn to relieve internal pressure and then retightened. Then they were
moved into the prewarmed water bath and gently shaken until only a
small ice pellet remained in the vials. Afterwards, the cryovials were
sprayed with ethanol (80%), and under sterile conditions, the cell sus-
pensions were then diluted 1:10 with warmed LG-DMEM “complete
medium” followed by centrifugation (500 g for 5 minutes). After cen-
trifugation, the supernatant was discarded and the cells were
resuspended with LG-DMEM “complete medium”. To reach a suffi-
cient number of cells for trilineage differentiation, the cells were first
expanded in LG-DMEM “complete medium” after the thawing
process.
2.4 | Cell viability
To assess the most effective cryopreservation medium for NP cells in
terms of cell viability, hNPCs' viability was assessed by automatic cou-
nting using flow cytometry for dead cells stained with propidium
iodide (#P4864-10ML; Sigma-Aldrich). Therefore, thawed hNPCs
were put into suspension with a buffer for flow cytometry (PBS, 0.5%
Human Serum Albumin, 0.5 mM EDTA [Sigma-Aldrich]) and then sta-
ined with propidium iodide (#P4864-10ML; Sigma-Aldrich). After
incubation (30 minutes at 4C), the cell suspensions were centrifuged
(500 g for 5 minutes) and washed twice with the buffer for flow cyto-
metry. For each condition, a minimum of 10 000 events was recorded
with the Cytoflex (Beckman Coulter; Brea) that was used for flow
cytometry. The following gating strategies were applied for flow cyto-
metry: All cells were first gated for whole-cell populations. Therefore,
the forward scattered height (FSC-H) was plotted against the side
scattered height (SSC-H). In a next step, to discriminate doubles from
single cells, the side scattered area (SSC-A) was plotted against the
SSC-H.
2.5 | Trilineage differentiation
2.5.1 | Overview
To test the multipotent potential of hNPCs, freshly isolated hNPCs at
passages 2 to 3 were driven to undergo osteogenesis, adipogenesis,
and chondrogenesis after subsequent expansion. Additionally, to
assess the influence of cryopreservation and the effect of the cryo-
preservation medium itself on the multipotent potential of hNPCs
(passages 3-5) that were previously frozen in one of five different
cryo-protectants were also driven to undergo trilineage differentia-
tion. Trauma and degenerated samples were analyzed separately due
to their different composition and general state. Degenerated tissue is
known to have an altered composition of the ECM, is osmotically
imbalanced, and contains increased levels of proinflammatory
cytokines.4,5,32
2.5.2 | Osteogenic differentiation
To test the osteogenic differentiation potential of hNPCs, cells were
seeded on a 12-well plate (#92012; TPP) with a density between
10 000 and 15 000 cells/cm2 and cultured either with control or osteo-
genic inductive medium for 21 days. The control medium consisted of
α - Modified Eagles Medium (α - MEM; #12000-063; Thermo Fisher
Scientific) containing 10% FBS, 1 mM sodium pyruvate, penicillin/strep-
tomycin/glutamine (P/S/G, 100 units/mL, 100 μg/mL and 292 μg/mL,
respectively) and 10 mM HEPES buffer solution (aka. α - MEM „com-
plete medium“). The osteogenic inductive medium consisted of the
same ingredients as the control medium with the addition of 100 nM
dexamethasone (#D1756), 10 mM β-glycerophosphate (#G9422), and
100 μM L-ascorbic acid 2-phosphate (#A8960; all from Sigma-Aldrich).
Medium change was performed twice a week.
2.5.3 | Adipogenic differentiation
To investigate the adipogenic differentiation potential of hNPCs, they
were seeded on a 12-well plate (#92012; TPP) with a density between
10 000 and 15 000 cells/cm2 and cultured either with a control
medium (α - MEM „complete medium“) or an adipogenic inductive
medium for 21 days. The adipogenic inductive medium consisted of
the same components as the control medium with the addition of
insulin (10 μg/mL; #I0516), 1 μM dexamethasone (#D1756),
isobutylmethylxanthine (IBMX; 10 μg/mL; #I7018), and 100 μM indo-
methacin (#I7378; everything from Sigma-Aldrich). Also, medium
change was performed twice a week.
2.5.4 | Chondrogenic differentiation
The chondrogenic differentiation potential was tested with hNPCs
cultured as 3D pellets. Therefore, between 250 000 and 300 000
hNPCs were centrifuged for 5 minutes at 500 g to a cell pellet and
cultured either with a control medium (α - MEM „complete medium“)
or chondrogenic inductive medium. The chondrogenic inductive
medium comprised high glucose Dulbecco's Modified Eagle Medium
(3.7 g/L; HG- DMEM; #52100-039; Thermo Fisher Scientific) sup-
plemented with 1 mM sodium pyruvate, penicillin/streptomycin/glu-
tamine (P/S/G, 100 units/mL, 100 μg/ mL and 292 μg/mL,
respectively), 10 mM HEPES buffer solution, 100 nM dexamethasone
(#D1756; Sigma- Aldrich), 1% insulin + transferrin + selenium (ITS),
1% bovine serum albumin (BSA) and linoleic acid (#I2521-5ML),
0.1 mM L-ascorbic acid-2-phosphate (#A8960; all from Sigma-
Aldrich), 1% minimum essential medium non-essential amino acid
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(MEM NEAA; #11140-035; Thermo Fisher Scientific) and 10 ng/mL
TGFβ-3 (#243-B3-002/CF; R&D Systems; Minneapolis). The pellets
were cultured for 21 days and the medium was changed twice
a week.
2.6 | Histology
Histological staining was performed for the trilineage differentiation
assays after 21 days of culture. Following steps were performed:
2.6.1 | Osteogenic lineage
First, hNPCs were washed three times with PBS. Then, the cells were
fixed with 4% formalin (#252549-1 L, Sigma-Aldrich) and then incu-
bated overnight at 4C. Afterwards, cells were rinsed twice with dis-
tilled water and 2% Alizarin red solution was added. After an
incubation time of 45 minutes in the dark at room temperature, the
cells were rinsed four times with distilled water and finally covered
with PBS. The Alizarin red staining consisted of 2% Alizarin red pow-
der (#A5533-25G; Sigma-Aldrich) dissolved into distilled water.
2.6.2 | Adipogenic lineage
Here, cells were washed twice with PBS. Afterwards, they were fixed
with 60% 2-propanol for 2 minutes at room temperature and replaced
with Oil-Red-O working solution. After 20 minutes of incubation time,
the cells were washed twice with PBS and finally covered with PBS. The
Oil-Red-O working solution was made of three parts Oil-Red-O stock
solution and two parts distilled water. The Oil-Red-O stock solution
consisted of 0.375% Oil-Red-O powder (#1.05230; Merck; Darmstadt,
Germany) dissolved into 2-propanol (#278475-1 L; Sigma-Aldrich).
2.6.3 | Chondrogenic lineage
At the end of the differentiation assay, the 3D pellets were washed
with PBS, fixed overnight in a 4% formalin solution at 4C. The next
day, the formalin was replaced with PBS and the pellets of each condi-
tion were embedded into HistoGel (#HG-4000-012, Thermo Fisher
Scientific) and transferred into histological cassettes (#81-0103-00;
Sanowa; Leimen, Germany), where they were dehydrated and
processed overnight with the STP 120 Spin Tissue Processor
(#813150; Thermo Fisher Scientific). After overnight dehydration, the
samples were embedded into paraffin and then cut into histological
sections (7 μm thickness). In a next step, the samples were either sta-
ined with Alcian blue (1% Alcian blue 8GX; #27221) or Safranin-O
(0.1% Safranin-O; #1.15948; Merck) including a counter-stain with
Fast green powder (0.02% Fast Green FCF; #1.04022; Merck) diluted
in distilled water. Finally, all samples were mounted using a coverslip
and with Eukitt (#03989-100ML; O. Kindler Inc.; Freiburg, Germany).
2.7 | Quantification of the trilineage
differentiation assay
2.7.1 | Quantification of the Alizarin red staining
content
To quantify the amount of Alizarin red staining present in the 12-well
plates, we put the stained matrix back into solution. Therefore, the
H2O was removed from all wells and replaced with 10%
cetylpyridinium chloride in 10 mM NaPO4 (#71645-1KG; Fluka). The
12-well plates were then put on an orbital shaker for 1 hour until all
the stain was solubilized. Afterwards, all samples were pipetted into a
96-well plate, and then the absorbance was read with a wavelength of
570 nm (SpectraMax M5; Bucher Biotec, Basel, Switzerland).
2.7.2 | Quantification of the Oil-Red-O staining
content
After staining, the Oil-Red-O positive signal in the 12-well plates had
to be put into solution for quantification. Therefore, the PBS was
removed and all wells were air-dried. Afterwards, 100% 2-propanol
was added to each well and put on an orbital shaker for 15 minutes.
The extracted Oil-Red-O staining was then transferred into the wells
of a 96-well plate and absorbance was measured with a wavelength
of 500 nm (SpectraMax M5).
2.7.3 | Quantification of the glycosaminoglycan
content in the Supernatant
To study the chondrogenic differentiation of the 3D pellets, the con-
centration of glycosaminoglycans (GAG) in the supernatant was mea-
sured at day 21 of cell culture, with the last exchange of medium
being carried out 4 days before the end of the culture. Therefore, a
stock solution of dimethylmethylene blue (DMMB) was prepared, con-
sisting of 0.0021% 1.9-dimethyl-methylene blue zinc chloride double
salt (#341088, Sigma- Aldrich), 0.2% sodium formate (#71541, Fluka),
absolute ethanol, and distilled water. By adding formic acid, the pH
was adjusted to 1.5. The DMMB was then added to the supernatant
of the respective samples and within 5 minutes, the absorbance could
be recorded at a wavelength of 595 nm (SpectraMax M5).
2.8 | Quantitative polymerase chain reaction
Total RNA was extracted using the GenElute Mammalian Total RNA
Miniprep Kit (#RTN70-1KT; Sigma- Aldrich). In contrast to the cells
from the adipogenic and osteogenic differentiation assays, the 3D pel-
lets from the chondrogenic differentiation assays first had to be lysed
with a tissue lyser (Retsch Inc.; Haan, Germany) before extracting the
RNA. Reverse transcription into cDNA was performed with the 5x
qRT SuperMix (#B24404, Bimake, San Francisco, California) together
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TABLE 2 Overview of all genes used for qPCR using Glycerinaldehyde 3-phosphate dehydrogenase (GAPDH) as a reference gene. Genes
analyzed for the chondrogenic lineage: SOX-9, aggrecan (ACAN), collagen type 2 (COL2), collagen type 1 (COL1) and collagen type 10 α 1
(COL10). For the osteogenic lineage, following genes were analyzed: Collagen type 1 (COL1), runt-related transcription factor 2 (RUNX2),
osteocalcin (OCN), osteopontin (OPN), osterix (OSX) and alkaline phosphatase (ALP). Genes analyzed for the adipogenic lineage: Adiponectin
(ADPN), peroxisome proliferator-activated receptor gamma (PPARγ) and CCAAT/enhancer-binding protein α (CEBPα)
Primers used for qPCR
Gene Gene ID Forward sequence Reverse sequence
GAPDH 2597 ATC TTC CAG GAG CGA GAT GGA GGC ATT GCT GAT GAT
SOX-9 6662 GAG ACT TCT GAA CGA GAG GGC TGG TAC TTG TAA TCC
ACAN 176 CAT CAC TGC AGC TGT CAC AGC AGC ACT ACC TCC TTC
COL2 1280 AGC AGC AAG AGC AAG GAG AA GTA GGA AGG TCA TCT GGA
COL1 1278 GTG GCA GTG ATG GAA GTG CAC CAG TAA GGC CGT TTG
COL10α1 1300 GAA TGC CTG TGT CTG CTT TCA TAA TGC TGT TGC CTG TTA
RUNX2 860 AGC AGC ACT CCA TAT CTC T TTC CAT CAG CGT CAA CAC
OCN 632 GCA GAG TCC AGC AAA GGT G CCA GCC ATT GATA CAG GTA GC
OPN 6696 ACG CCG ACC AAG GAA AAC TC GTC CATA AAC CAC ACT ATC ACC TCG
OSX 121 340 CAG GCT ATG CTA ATG ATT ACC GGC AGA CAG TCA GAA GAG
ALP 249 CCT TCA CTG CCA TCC TGT A CGC CTG GTA GTT GTT GTG
ADPN 9370 CCG TGA TGG CAG AGA TGG TAT ACA TAG GCA CCT TCT CCA G
PPARγ 5468 ACG AAG ACA TTC CAT TCA CAA GA CTC CAC AGA CAC GAC ATT CAA
CEBPα 1050 CAA GAA CAG CAA CGA GTA GTC ATT GTC ACT GGT CAG
F IGURE 1 Flow cytometry analysis to assess the cell viability of hNPC populations after freezing them in five different cryopreservation
media. A, Representative image of unstained hNPC population of one donor. B, Representative image of hNPC population of one donor stained
with propidium iodide. Living cells are highlighted in green and dead cells in red. C, Graphical representation of living and dead NP cells that were
previously frozen either in CMPC, CMDC, CnT, CS10, or MesenCult (mean ± SD, N = 6). The results show no significant differences when
comparing the cell viability of the different groups with each other
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with the MyCycler thermal cycler (#170-9703, Bio-Rad Laboratories;
Hercules, California). The cycling parameters were: 25C for 5 minutes,
followed by 42C for 30 minutes, and then 85C for 5 minutes. Real-
time quantitative polymerase chain reaction (qPCR) was performed
with the CFX96 Real-Time System (#185-5096; Bio-Rad Laboratories)
using the primers of interest (Table 2) together with the 2x SYBR
F IGURE 2 Legend on next page.
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green master mix (#B21202; Bimake) undergoing a two-step protocol
for 45 cycles with a denaturation temperature of 95C for 15 seconds
and a combined annealing and extension at 61C for 30 seconds. To
determine the gene expression, the threshold cycles (Ct) of the differ-
ent genes were analyzed and the ΔΔCt was calculated using GAPDH
as a reference gene. In the end, 2-ΔΔCt was calculated to get the fold
change of each gene. Samples with a Ct above 35 cycles or with an
unconventional melting curve were excluded.
2.9 | Statistical analysis
For all data, a non-parametric distribution was assumed, and the
results are presented as mean ± standard deviation (SD). Cell viability
after freezing was analyzed as single replicates by two-way ANOVA
followed by a Tukey's multiple comparison test. Alizarin red, Oil-
Red-O, and GAG quantification were analyzed in technical duplicates
by Kruskal-Wallis tests and Dunn's multiple comparisons tests. Rela-
tive gene expression was analyzed as single replicates by two-way
ANOVA followed by a Tukey's multiple comparison test. Significance
was set at P < .05 and all tests were performed using GraphPad Prism
(version 7.0d for Mac OS X, GraphPad Software; San Diego, Califor-
nia). All graphs are indicated with N = number of biological replicates.
3 | RESULTS
3.1 | Cell Viability of cryo-preserved hNPCs
To determine to most efficient cryopreservation medium for hNPCs
in terms of viability and maintenance of the differentiation poten-
tial, hNPCs were resuspended either in the “commonly used” media
(CMPC or CMDC) or in the commercially available media (CnT,
CS10 or MesenCult), and then frozen. The hNPCs showed very
similar cell viabilities independent of the cryopreservation media
used and non-significant differences when comparing the different
groups with each other (CMPC: 82.0 ± 4.7%, CMDC: 81.9 ± 4%,
CnT: 83.4 ± 3.6%, CS10: 82.8 ± 7.6% and MesenCult: 81.5 ± 5.5%).
This indicates that “commonly used” cryopreservation media and
commercially available media both performed the same in terms of
cell viability (Figure 1).
3.2 | Osteogenic differentiation
From a histological point of view, differences could be observed
between trauma cells cultured in the control medium and respective
cells cultured in the osteogenic inductive medium. Sporadically, areas
of mineralized matrix stained with Alizarin red could be seen on the
osteogenic inductive samples, while no staining was visible in control
samples (Figure 2A,B). Regarding the histological findings from previ-
ously frozen cells, samples frozen in CMPC and CMDC showed a con-
siderable amount of Alizarin red stained areas when culturing them in
osteogenic inductive medium. However, no sign of osteogenic differ-
entiation could be found in the samples that were frozen in CnT,
CS10, or MesenCult (Figure 2A-E).
When analyzing the absorbance of solubilized Alizarin red stained
matrix, fresh trauma samples cultured in osteogenic inductive medium
and the ones frozen in CMPC and CMDC showed a relatively, but non-
significantly, higher amount of Alizarin red when comparing them to
the control set at 100 ± 86.9% (Osteo: 435 ± 407%, CMPC: 718
± 1029%, CMDC: 1120 ± 2085%, CnT: 73.3 ± 28.8%, CS10: 106%,
MesenCult: 87.6%) (Figure 2F). Looking at the relative osteogenic gene
expression profile of fresh trauma samples, only ALP showed a signifi-
cant higher gene expression (Osteo: 9.7 ± 12.2-fold increase). All other
genes did not differ from the control in any significant way (Figure 2G).
On the other hand, hNPCs from degenerated IVDs did not show
any microscopical evidence of matrix mineralization nor any indication
F IGURE 2 Representative images of the osteogenic differentiation assays. A, The hNPCs from trauma IVDs cultured in control medium or
from the CS10 and MesenCult condition and then stained with Alizarin red. B, The hNPCs from trauma IVDs cultured in osteogenic inductive
medium and stained with Alizarin red. C, Alizarin red stained single well of a 12-well plate with hNPCs from trauma IVDs that were previously
frozen in CMPC and then cultured in osteoinductive medium. D, Alizarin red stained single well of a 12-well plate with hNPCs from trauma IVDs
that were previously frozen in CMDC and then cultured in osteogenic inductive medium. E, Alizarin red stained single well of a 12-well plate with
hNPCs from trauma IVDs that were previously frozen in CnT and then cultured in osteogenic inductive medium. F, Relative quantification of the
amount of solubilized Alizarin red from either fresh or previously frozen trauma hNPCs that were cultured in osteogenic inductive medium
relative to cells cultured in control medium, which are set at baseline 100% (mean ± SD, N = 4 for Control, Osteo, CMPC, CMDC and CnT, N = 1
for CS10 and MesenCult). G, Osteogenic gene expression profile of trauma hNPCs relative to the control at baseline 1 (mean + SD, N = 4 for
Control, Osteo, and CnT; mean + SD, N = 3 for CMPC and CMDC, N = 1 for CS10, MesenCult, and all osterix (OSX) results). H, Relative
quantification of the amount of solubilized Alizarin red from either fresh or previously frozen hNPCs from degenerated IVDs that were cultured in
osteogenic inductive medium relative to cells cultured in control medium, which are set at baseline 100% (mean ± SD, N = 2). I, Osteogenic gene
expression profile of hNPCs from degenerated IVDs relative to the control at baseline 1 (mean + SD, N = 2 for all samples except OCN is N = 1
due to poor quality results of one donor). Nomenclature: Control: Fresh hNPCS cultured in control medium; Osteo: Fresh hNPCS cultured in
osteogenic inductive medium; CMPC: hNPCs cryopreserved in CMPC and subsequently cultured in osteogenic inductive medium; CMDC: hNPCs
cryopreserved in CMDC and subsequently cultured in osteogenic inductive medium; CnT: hNPCs cryopreserved in CnT and subsequently
cultured in osteogenic inductive medium; CS10: hNPCs cryopreserved in CS10 and subsequently cultured in osteogenic inductive medium;
MesenCult: hNPCs cryopreserved in MesenCult and subsequently cultured in osteogenic inductive medium. The following genes were analyzed:
Collagen type I (COL1), runt-related transcription factor 2 (RUNX2), osteocalcin (OCN), alkaline phosphatase (ALP), osteopontin (OPN) and osterix
(OSX). *P < .05, no indication: P ≥ .05
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of osteogenesis when the absorbance of solubilized Alizarin red was
measured (Figure 2H). Furthermore, no osteogenic related gene was
significantly up- or downregulated. Nevertheless, osteogenic related
genes of degenerated samples were mostly stronger expressed, how-
ever not significantly, than trauma samples. This includes the genes
COL1, RUNX2, OCN, OPN, and OSX (Figure 2I).
F IGURE 3 Legend on next page.
CROFT ET AL. 9 of 15
3.3 | Adipogenic differentiation
Regarding the adipogenic differentiation potential of trauma hNPCs,
lipid droplets were present with fresh cells, cultured with adipogenic
inductive medium, as well as with cryopreserved (CMPC, CMDC, and
CnT) cells. Numerous lipid droplets were visible even without the
proper stain solution (Figure 3B-E). In contrast, no lipid droplets were
visible in the samples cultured with control medium or with trauma
cells that were either frozen in CS10 or MesenCult (Figure 3A).
Due to challenging difficulties in staining a series of fresh cells
using an incorrect Oil-Red-O staining solution, all adipogenic trauma
samples were compared with a single control where the staining
succeeded. Although a clear difference in adipogenic differentiation
was visible between the control and some adipogenic inductive trauma
samples (namely Adipo, CMPC, CMDC, and CnT), this could not be con-
firmed when measuring the absorbance of solubilized Oil-Red-O and as
a result, no significant differences were found (Figure 3F).
In addition, no significant differences were seen for any condition
with respect to the relative adipogenic gene expression profile of trauma
hNPCs. Nevertheless, especially ADPN (Adipo: 1831.9 ± 1709.6-fold
increase, CMPC: 2280.9 ± 3241.2-fold increase, CMDC: 1821.4
± 21 821.6-fold increase, CnT: 1096.0 ± 975.1 increase, CS10: 486.9-fold
increase, MesenCult: 205.3-fold increase), but also CEBPα (Adipo: 80.0
± 56.7-fold increase, CMPC: 254.0 ± 162.3-fold increase, CMDC: 166.3
± 121.4-fold increase, CnT: 364.0 ± 420.8 increase, CS10: 91.3-fold
increase, MesenCult: 77.6-fold increase) displayed a strong trend for
upregulated gene expression. However, PPARγ showed hardly any
differences compared to the control (Figure 3G).
The quantification of solubilized Oil-Red-O from degenerated
IVDs, hNPCs cultured in adipogenic inductive medium also revealed
no significant differences compared to the control (Figure 3H). How-
ever, in contrast to the trauma cells, no lipid droplets could be found
microscopically.
Despite the missing lipid droplets, significant upregulations of
ADPN were observed for the CS10 condition (92.5 ± 73.1-fold
increase) with hNPCs derived from degenerated IVDs. Moreover,
ADPN was consistently upregulated, although not significantly and also
much weaker than the trauma samples (Adipo: 112.8-fold increase,
CMPC: 37.3 ± 41.7-fold increase, CMDC: 5.9 ± 6.2-fold increase, CnT:
8.5 ± 9.8-fold increase, MesenCult: 23.6 ± 20.2-fold increase). Further-
more, both CEBPα as well as PPARγ did not display any significant
changes, even though CEBPα tended to be upregulated for all
conditions. Thus, based on the qPCR results, it can be stated that cryo-
preservation had no significant influence on the cell's adipogenic
differentiation potential, as no gene was significantly higher or lower
expressed when comparing fresh cells with cryopreserved ones
(Figure 3I).
3.4 | Chondrogenic differentiation
To analyze chondrogenic differentiation, 3D pellet samples were
stained with Alcian blue. The chondrogenic pellets with cells from
trauma patients were larger when examined by eye, and produced
more GAG (stained in deep blue) than the control pellets
(Figure 4A,B). Moreover, previously frozen cells, with subsequent
culture in the chondrogenic inductive medium, showed results simi-
lar to fresh cells. Noteworthy, areas that were intensively stained
with Alcian blue were predominantly located at the edges of the
3D pellet samples (Figure 4C-E).
To study the chondrogenic differentiation of the 3D pellets,
the concentration of GAG in the supernatant was determined
after 21 days of culture. Even though the results are not signifi-
cant, out of all conditions, fresh trauma cells that were cultured in
chondrogenic inductive medium released the largest amount of
GAG into the supernatant (Control: 100 ± 9.0%, Chondro: 111.4
± 13.6%). Previously frozen chondrogenic trauma cells released
similar or slightly less GAG than the control (CMPC: 67.3 ± 23.6%,
CMDC: 101.7 ± 20.7%, CnT: 79.3 ± 19.2%, CS10: 101.7%, MesenCult:
90.1%) (Figure 4F). However, for the majority of conditions, a strong
F IGURE 3 Representative images of the adipogenic differentiation assays. A, The hNPCs from trauma IVDs cultured in control medium or from
the CS10 and MesenCult condition. B, The hNPCs from trauma IVDs cultured in adipogenic inductive medium. Lipid droplets are indicated with
arrows. C, Oil-Red-O stained single well of a 12-well plate with hNPCs from trauma IVDs that were previously frozen in CMPC and then cultured in
adipogenic inductive medium. D, Oil-Red-O stained single well of a 12-well plate with hNPCs from trauma IVDs that were previously frozen in
CMDC and then cultured in adipogenic inductive medium. E, Oil-Red-O stained single well of a 12-well plate with hNPCs from trauma IVDs that
were previously frozen in CnT and then cultured in adipogenic inductive medium. F, Relative quantification of the amount of solubilized Oil-Red
from either fresh or previously frozen trauma hNPCs that were cultured in adipogenic inductive medium relative to cells cultured in control medium,
which are set at baseline 100% (mean ± SD, N = 4 for CMPC, CMDC, and CnT, N = 1 for Control, Adipo, CS10, and MesenCult). G, Adipogenic gene
expression profile of trauma hNPCs relative to the control at baseline 1 (mean + SD, N = 4 for Control, Adipo, CMPC, CMDC and CnT, N = 1 for
CS10, and MesenCult). H, Relative quantification of the amount of solubilized Oil-Red from either fresh or previously frozen hNPCs from
degenerated IVDs that were cultured in adipogenic inductive medium relative to cells cultured in control medium, which are set at baseline 100%
(mean ± SD, N = 2). I, Adipogenic gene expression profile of hNCPs from degenerated IVDs relative to the control at baseline 1 (mean + SD, N = 2).
Nomenclature: Control: Fresh hNPCS cultured in control medium; Osteo: Fresh hNPCS cultured in adipogenic inductive medium; CMPC: hNPCs
cryopreserved in CMPC and subsequently cultured in adipogenic inductive medium; CMDC: hNPCs cryopreserved in CMDC and subsequently
cultured in adipogenic inductive medium; CnT: hNPCs cryopreserved in CnT and subsequently cultured in adipogenic inductive medium; CS10:
hNPCs cryopreserved in CS10 and subsequently cultured in adipogenic inductive medium; MesenCult: hNPCs cryopreserved in MesenCult and
subsequently cultured in adipogenic inductive medium. The following genes were analyzed: Adiponectin (ADPN), CCAAT/enhancer-binding protein
alpha (CEBPα) and peroxisome proliferator-activated receptor-gamma (PPARγ). *P < .05, no indication: P ≥ .05
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F IGURE 4 Representative images of the chondrogenic differentiation assays. A, The hNPCs from trauma IVDs cultured in controlmediumor from the
CS10 andMesenCult condition and stainedwithAlcian blue. B, The hNPCs from trauma IVDs cultured in chondrogenic inductivemediumand stainedwith
Alcian blue. C, Alcian blue stained hNPCs from trauma IVDs thatwere previously frozen inCMPCand then cultured in chondrogenic inductivemedium.D,
Alcian blue stained hNPCs thatwere previously frozen inCMDCand then cultured in chondrogenic inductivemedium. E, Alcian blue stained hNPCs from
trauma IVDs thatwere previously frozen inCnT, CS10orMesenCult and then cultured in chondrogenic inductivemedium. F, Relative quantification of the
amount of glycosaminoglycan released into the supernatant fromeither fresh or previously frozen traumahNPCs thatwere cultured in chondrogenic inductive
medium relative to cells cultured in controlmedium,which are set at baseline 100% (mean ± SD,N=4 forControl, Chondro, CMPC,CMDCandCnT,N=1 for
CS10 andMesenCult). G, Chondrogenic gene expression profile of trauma hNPCs relative to the control at baseline 1 (mean + SD,N=4 forControl, Chondro,
CMPC,CMDCandCnT,N=3 forCOL2withChondro due to poor quality results of onedonor, N=1 forCS10 andMesenCult). H, Relative quantification of
the amount of glycosaminoglycan released into the supernatant fromeither fresh or previously frozen hNPCs fromdegenerated IVDs thatwere cultured in
chondrogenic inductivemedium relative to cells cultured in controlmedium,which are set at baseline 100% (mean ± SD,N=2). I, Chondrogenic gene
expression profile of hNPCs fromdegenerated IVDs relative to the control at baseline 1 (mean + SD,N=2).Nomenclature: Control: Fresh hNPCS cultured in
controlmedium;Osteo: FreshhNPCS cultured in chondrogenic inductivemedium;CMPC: hNPCs cryopreserved inCMPCand subsequently cultured in
chondrogenic inductivemedium;CMDC: hNPCs cryopreserved inCMDCand subsequently cultured in chondrogenic inductivemedium;CnT: hNPCs
cryopreserved inCnT and subsequently cultured in chondrogenic inductivemedium;CS10: hNPCs cryopreserved inCS10 and subsequently cultured in
chondrogenic inductivemedium;MesenCult: hNPCs cryopreserved inMesenCult and subsequently cultured in chondrogenic inductivemedium. The following
geneswere analyzed: Aggrecan (ACAN), SOX-9, collagen type II (COL2), collagen type I (COL1), and collagen typeX (COL10).No indication:P ≥ .05
CROFT ET AL. 11 of 15
trend for COL2 expression was found compared to the control
(Chondro: 244.1 ± 172.8-fold increase, CMPC: 750.6 ± 1343.4, CMDC
654.7 ± 1093.7-fold increase, CnT: 741.8 ± 1108.4-fold increase, CS10:
11.3-fold increase, MesenCult: 2.2-fold increase). Contrarily, the
other chondrogenic related genes ACAN and SOX-9 did not differ from
the control at all, and also COL1 showed no difference. Finally, COL10
was extensively expressed by trauma hNPCs, but also did not
change significantly (Chondro: 14.8 ± 6.4-fold increase, CMPC: 10.1
± 14.1-fold increase, CMDC: 7.9 ± 14.6-fold increase, CnT: 9.0 ± 14.5
increase, CS10: 21.9-fold increase, MesenCult: 39.5-fold increase)
(Figure 4G).
A further indication of how strong chondrogenic differentiation
was can be seen when calculating the COL2 to COL1 ratio (Chondro:
162, CMPC: 966, CMDC: 926, CnT: 1170, CS10: 12.6, MesenCult:
1.8). Especially the Chondro, CMPC, CMDC, and CnT conditions show
relatively high ratios and therefore indicate notable chondrogenic
differentiation.
Regarding the chondrogenic differentiation potential of hNPCs
from degenerated IVDs, all samples released a relatively higher
amount of GAG into the supernatant. The results were not signifi-
cant compared to the control set at 100 ± 4.0% (Chondro: 136.9
± 6.0%, CMPC: 138.6 ± 13.7%, CMDC: 149.6 ± 19.3%, CnT: 159.6
± 39.7%, CS10: 166.6 ± 14.2%, MesenCult: 147.0 ± 11.0%)
(Figure 4H).
Concerning the expression of chondrogenic related genes with
hNPCs from degenerated IVDs, again none of the genes were either sig-
nificantly up- or downregulated. Only COL10 was noticeably higher
expressed (Chondro: 191.2 ± 256.9-fold increase, CMPC: 369.0
± 389.9-fold increase, CMDC: 226.1 ± 316.7-fold increase, CnT: 198.7
± 137.6 increase, CS10: 250.5 ± 295.1-fold increase, MesenCult: 364.1
± 465.3-fold increase) (Figure 4I).
Also when calculating the COL2 to COL1 ratios, hNPCs derived
from a degenerated IVD display much lower ratios than the trauma




This study showed that hNPCs can be cryo-preserved with “commonly
used” cryopreservation media just as well as with commercially available
media without any significant differences concerning cell viability. Further-
more, no changes in cell proliferation were observed when comparing the
different formulations. An explanation for the similar performance of all
five cryopreservation media could be that all formulations are DMSO
based and consequently have a very comparable mechanism of action.
These results nicely show that researchers, working with hNPCs, can just
as well cryo-preserve their cells in “commonly used” cryo-medium, which
are potentially more affordable than commercially available media.
Throughout the literature, many studies showed comparable results with
different cell types regarding their viability after cryopreservation.30 To our
knowledge, no study analyzed the effect of cryopreservation on the viabil-
ity and the trilineage potential of hNPCs. However, Hiraishi et al. (2018)
transplanted cryo-preserved human NP cells into degenerated canine
IVDs. They demonstrated, that thawed cells can arrest further degenera-
tion by maintaining matrix features just as well as precultured cells.33
Nevertheless, DMSO-based products still face some challenges for
successful future cell-based therapy. Despite the beneficial cryoprotective
effects of DMSO, it is also known to be chemically toxic for cells, particu-
larly in its liquid phase.34 In clinical use, DMSO has been shown to cause
mild to severe adverse reactions with human tissues.35-37 Hence, it would
be essential to properly remove any DMSO residues from frozen–thawed
samples before considering regulatory affairs for cell therapy in patients
in a good manufacturing practise (GMP)-compliant environment.38
4.2 | Osteogenic differentiation
With the osteogenic inductive medium, little to no evidence of osteo-
genesis was seen in fresh trauma cells as well as in samples previously
frozen in one of the cryopreservation media. However, a high donor
variability was seen in measurements of solubilized Alizarin red absor-
bance: Trauma hNPCs showed either strong mineralization of the
ECM or no mineralization at all. Regarding the relative osteogenic
gene expression profile, except for an up-regulation of ALP, all other
osteogenic related genes either did not significantly change or were
even slightly downregulated when comparing them to their controls.
Concerning the hNPCs derived from degenerated IVDs, no signs of
ECM mineralization could be observed. However, osteogenic related
genes were generally higher upregulated with degenerated samples
than with trauma samples and therefore showing at least some evi-
dence for osteogenic differentiation. Furthermore, the cryopreserva-
tion media tested have neither increased the hNPCs osteogenic
potential nor weakened it.
Similar findings concerning the ossification potential of IVD
cells of surgery tissue have also been reported by a recent report
by Brown et al. (2018). They stated that hNPCs can calcify their
ECM and can therefore become osteogenic in monolayer.39 Fur-
thermore, Haschtmann et al. (2012) found in a rabbit disc organ cul-
ture modal that BMP2 and TGFβ-3 could induce osteogenesis in
differentiated AF cells.40 However, osteogenesis occurred inconsis-
tently in our screened donors and only within a minority of the
tested samples.39 These limited osteogenic capabilities are presum-
ably either due to the existence of MSCs in the NP, so-called NP-
MSCs described by Blanco et al. (2010), or this could be due to the
presence of Tie2 positive progenitor cells in our samples. Previous
studies proved that NP-MSCs and Tie2 positive cells in human,
mouse and bovine NP tissue can undergo osteogenic differentia-
tion.16,19 However, these results are based on the culture of very
uniform Tie2 positive cell groups and not on a heterogeneous cell
population, as used in our study. Furthermore, Tekari et al. (2016)
showed that a mixed NP cell population manages to form some
mineralization, but much less than pure Tie2 positive cells and
therefore supports our findings.19
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4.3 | Adipogenic differentiation
Concerning the adipogenic differentiation potential of hNPCs, three
out of four trauma samples, cultured in adipogenic inductive medium,
were able to form lipid droplets, which could be microscopically
detected. Even though the Oil-Red-O stain was unsuccessful in the
majority of fresh hNPCs, the lipid droplets were still visible. Contrary
to the microscopical findings, no significant differences could be
observed when measuring the absorbance of the solubilized Oil-
Red-O. This is probably due to the higher unspecific staining the
control exhibited compared to the adipogenic inductive samples and
consequently biased the results. When looking at the qPCR results
from trauma cells, especially ADPN was highly expressed for all condi-
tions and upregulated up to 2281 times compared to the control.
However, as with the osteogenic samples, excessive donor variability
was noted, which made any significant conclusions impossible. Also,
CEBPα was notably expressed with values ranging between a 77-fold-
and a 364-fold-upregulation, depending on the condition. Only PPARγ
did not show any evident changes compared to the control. Addition-
ally, no significant changes between the gene expression of freshly
isolated cells and cryopreserved cells were seen, indicating that
cryopreservation did not have a negative influence on the adipogenic
differentiation potential on trauma hNPCs, at least from a genetic
point of view.
Regarding the adipogenic differentiation potential of hNPCs from
degenerated IVDs, no sign of any lipid droplets could be microscopi-
cally observed. Even after measuring the Oil-Red-O absorbance of
these samples, no significant differences between the conditions
could be detected, neither with fresh cells nor with cryopreserved
samples. However, the adipogenic related gene expression revealed a
significant upregulation of ADPN for hNPCs that were previously
frozen with CS10 and then cultured with inductive medium, which
indicates at least a minimum of adipogenic differentiation. Further-
more, all genes were generally lower expressed with cells derived
from degenerated discs compared to trauma ones. Moreover, as with
the osteogenic samples, cryopreservation had no significant effect on
the cell's differentiation potential.
These results seem to be very interesting, as on the one hand, we
could partially confirm the findings of Blanco et al. (2010) who did not
manage to produce any lipid droplets when culturing human NP cells
from degenerated IVDs in adipogenic inductive medium.16 On the other
hand, we successfully managed to produce lipid droplets with hNPCs
derived from trauma IVDs, even after cryopreservation. Furthermore, the
here presented results encourage the published data from Tekari et al.
(2016), who showed adipogenic differentiation of bovine NPCs.19
4.4 | Chondrogenic differentiation
Concerning the chondrogenic differentiation potential of trauma
hNPCs, evidence for chondrogenic differentiation could be found with
the Alcian blue staining for example. Especially at the border of the
3D pellets that were cultured in chondrogenic medium, a lot of GAG
was produced and multiple chondrocyte-like cells were visible. In con-
trast, the intensity of the Alcian blue stain in the control pellets was
much weaker and the pellets were generally smaller than the
chondrogenic pellets. Furthermore, relative gene expression of the
trauma samples cultured in chondrogenic medium showed particularly
a relatively high COL2 expression, which led to remarkable COL2 to
COL1 ratios and therefore indicate notable chondrogenic differentia-
tion. Nevertheless, large donor variability was present and conse-
quently prevented any kind of significant differences between the
control and the chondrogenic inductive samples. ACAN and SOX-9
did not differ from the control and therefore, could not underline the
chondrogenic potential of hNPCs as it was the case with COL2. Gen-
erally, the expression of COL1 did not change, neither in fresh cells
nor in cryopreserved samples. However, against our hypothesis, also
COL10 was higher expressed than the control, even though not signif-
icantly, indicating a hypertrophic state of the respective samples. This
can be explained by the strong impact of TGFβ-3, which we used in
our chondrogenic inductive medium. Additionally, the upregulation of
COL10 in the chondrogenic samples may also explain why the trauma
samples cultured in chondrogenic inductive medium produced about
the same amount of GAG on day 21 as the control. The peak of GAG
production was probably already reached many days earlier.
Cells derived from degenerated IVDs showed a similar trend as
the trauma samples in terms of gene expression. However, COL2 and
SOX-9 were generally lower expressed than the trauma cells. As seen
with the trauma samples, COL10 was again non-significantly
upregulated and surprisingly, even stronger than with the respective
trauma hNPCs. Additionally, ACAN and COL1 did not change or were
expressed somewhat higher than the control, but also not signifi-
cantly. Interestingly, all hNPCs that were cultured in chondrogenic
inductive medium displayed higher but non-significant accumulation
of GAG in the supernatant, showing at least some evidence of
chondrogenic differentiation from this point of view. Furthermore, it
can be stated that release of GAG into the supernatant did not signifi-
cantly change between fresh hNPCs and previously cryopreserved
cells. This indicates that cryopreservation most likely did not influence
the chondrogenic differentiation potential of these cells.
4.5 | Study weaknesses and limitations
One limitation of this study is that only the cell viability and their dif-
ferentiation potential before and after freezing was analyzed. Other
parameters that could have been taken into consideration for the
freezing assays would have been the cell proliferation rate, the cell's
morphology, metabolism, or cell surface markers. However, a recent
study involving BMSCs showed that cryopreservation does not affect
the cell's surface markers, their proliferation rate, or their morphol-
ogy.31 Even though BMSCs are not the same as hNPCs, similar results
are likely to be expected with hNPCs. Another limitation concerning
the freezing assay is that no long-term data are available. Due to the
strict and tight schedule of this study, cells could be frozen at −150C
only for a single week. Nevertheless, as the cellular metabolism almost
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comes to a standstill with so low temperatures and therefore, it can
be assumed that no big changes are expected even after multiple
weeks or even months of cryopreservation.29
An additional limitation of these types of donor studies was that
trauma patients cannot be strictly be separated from patients with
degenerated IVDs. We cannot fully exclude that trauma patients
might have had an age appropriate degenerated IVD as for these
patients no pre-operative magnetic resonance image (MRI) was taken.
Another strong limitation of this study was that no Tie2 positive
sorted human cells were investigated at any time point. Previous stud-
ies like Frauchiger et al. (2019) dealt with only Tie2 positive NP
cells.41 However, human-derived Tie2 positive cells were much fewer
detected. This study also misses out to provide any evidence for CFUs
in semi-solid cellulose assay as it was not possible to perform these
CFU assays in a meaningful way with human Tie2 positive cells.
Bovine-derived Tie2 positive cells could be much more isolated as
these animals are very young and NP cells from several animals
could be pooled. This enabled Frauchiger et al. (2019) and Sakai et al.
(2018) to study the culture conditions of these cells much more in
detail.18,41
4.6 | Future perspective
Future studies should focus on the responsible hNPC subpopulation
responsible for their trilineage potential. Therefore, specific cell
populations like Tie2 positive cells, CD73, CD90, and CD105 positive
cells could be sorted and isolated from the remaining hNPCs and then
separately tested for their trilineage potential. It is likely, that interac-
tion and cooperation of progenitor cells, which equally contribute to
the IVD's regeneration potential, is mainly responsible for the cell's
stemness, rather than a single cell population. Finally, there is also the
possibility that other undiscovered progenitor cells exist in the NP,
which could have a huge impact on the stemness of hNPCs.
4.7 | Conclusion
In this study, the freezing assay showed that “commonly used” cryo-
preservation media seem to be just as efficient as the commercially
available media in terms of cell viability for hNPCs. Therefore, it is
more economical using either a commonly applied cryo-medium for
progenitor cells or one for differentiated cells instead of a commer-
cially available cryopreservation medium. Regarding the trilineage dif-
ferentiation potential of hNPCs, trauma samples showed sporadic
mineralization of their ECM but no indication of differentiation based
on the results of osteogenic related genes. Concerning the trauma
cell's adipogenic differentiation potential, the occasional production
of lipid droplets was observed, however, when quantifying the solubi-
lized Oil-Red-O, no significant differences were found compared to
the control. Nevertheless, adipogenic related genes like ADPN and
CEBPα showed relatively high, but non-significant, upregulations.
Trauma cell pellets cultured in chondrogenic inductive medium and
subsequently stained with Alcian blue revealed a higher production of
GAG than controls and COL2 to COL1 ratios of up to 1000. However,
the amount of GAG released into the supernatant was similar for all
samples. Regarding the samples derived from degenerated discs, the
adipogenic and chondrogenic differentiation potential was generally
less pronounced in hNPCs from degenerated IVDs than from trauma
discs. Surprisingly, however, hNPCs from degenerated samples
showed mostly a higher, but non-significant, expression of osteogenic
related genes than trauma cells, indicating a more successful differen-
tiation towards osteogenesis than trauma samples.
Overall, cryopreservation did not broadly affect the differentia-
tion potential of hNPCs, indicating that hNPCs are perfectly fine if
they are being cryo-preserved. However, extensive donor variations
could be observed, which were maintained before and after freezing.
Nevertheless, the results are promising and therefore clinical trials
considering hNPCs for cell-based IVD regeneration could be taken
into consideration.
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